Snowball logo
logo
6039

Dali Pharmaceutical Co Ltd

603963 • SHG
¥1.18¥0.00  (0%)
Estimate
EPS
-0.11
Beta
0.082
About the company
Ticker
603963
ISIN
CNE100002VL4
Country
China
Sector (GICS)
Healthcare
Dali Pharmaceuticalco.,Ltd researches, develops, produces, and sells pharmaceutical products in China. It develops Chinese and Western medicine injection. The company's products include xingnaojing, shenmai, and astragalus injections, as well as citicoline injections. It also has patents, including invention patents and utility models. The company was founded in 1996 and is headquartered in Dali, China.

Frequently asked questions

What sector does Dali Pharmaceutical Co Ltd (603963) operate in?

Dali Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Dali Pharmaceutical Co Ltd (603963) current stock price?

As of the latest data, Dali Pharmaceutical Co Ltd stock price is CN¥1.18, with a previous close of CN¥1.18.

What is Dali Pharmaceutical Co Ltd (603963) current market capitalization?

Dali Pharmaceutical Co Ltd market cap is approximately 259.25 million.

What is Dali Pharmaceutical Co Ltd (603963) Earnings Per Share (EPS)?

The trailing EPS is -CN¥0.11.

Does Dali Pharmaceutical Co Ltd (603963) pay dividends?

No. Dali Pharmaceutical Co Ltd does not pay a dividend.

What is Dali Pharmaceutical Co Ltd (603963) beta (volatility) score?

Dali Pharmaceutical Co Ltd has a beta of 0.082, indicating lower volatility than the overall market.